Human Embryonic Stem Cell Differentiation Without Feeder Layers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a significant need to develop conditions for establishing pluripotent stem cell lines that can be expanded to address clinical needs while retaining the potential to differentiate into pancreatic endocrine cells, pancreatic hormone expressing cells, or pancreatic hormone secreting cells, with existing methods being inefficient and not fully applicable to human embryonic stem cells.

Innovation Solution

A method involving culturing pluripotent stem cells through a series of differentiation steps using activin A, Wnt ligands, fibroblast growth factors, retinoic acid, and other signaling pathway inhibitors to progressively differentiate into cells expressing markers characteristic of definitive endoderm, pancreatic endoderm, and ultimately pancreatic endocrine lineages, all without the need for a feeder cell layer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If existing differentiation methods are used to generate pancreatic endocrine cells from pluripotent stem cells, then cell production can be achieved, but the differentiation efficiency is low and the methods are not fully applicable to human embryonic stem cells

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoidapplicability to human embryonic stem cells
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically optimizing culture conditions including serum concentration (reducing from high to low), growth factor concentrations (activin A, Wnt ligands, fibroblast growth factors, retinoic acid), and differentiation time points to achieve efficient human embryonic stem cell differentiation into pancreatic endocrine cells

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The differentiation process is segmented into distinct stages: formation of definitive endoderm, transition to pancreatic endoderm, and final differentiation to pancreatic endocrine cells. Each stage uses specific signaling pathway inhibitors and growth factors to guide cells through the developmental sequence

Inventive Principle:
Principle #1Segmentation

2Ease of operation

If traditional culture methods with feeder cell layers are used, then stem cell maintenance is easier, but the complexity of the culture system increases and may interfere with differentiation

Engineering Contradiction:
Improvestem cell maintenanceVSAvoidculture system complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent removes the feeder cell layer from the culture system, replacing it with a defined culture medium containing specific growth factors and signaling pathway inhibitors. This extraction eliminates the complexity and potential interference of feeder cells while maintaining stem cell support functions

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The culture system is designed to be self-sufficient using chemically defined components rather than requiring living feeder cells. The medium contains all necessary factors (activin A, Wnt ligands, fibroblast growth factors, retinoic acid) to support stem cell maintenance and guide differentiation without external cellular support

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS11708562B2Differentiation of human embryonic stem cells
Publication Date: 2023.07.25 JANSSEN BIOTECH INC
  • US11708562B2 patent drawing
  • US11708562B2 patent drawing
  • US11708562B2 patent drawing

AI summary

The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.